{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:03:35Z","timestamp":1789715015038,"version":"4.0.1"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,9,20]],"date-time":"2014-09-20T00:00:00Z","timestamp":1411171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pathobiol Rep"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s40139-014-0050-2","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T11:05:28Z","timestamp":1411124728000},"page":"143-153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Mouse Models of Liver Fibrosis Mimic Human Liver Fibrosis of Different Etiologies"],"prefix":"10.1007","volume":"2","author":[{"given":"Allyson K.","family":"Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Maroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Marzioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed T.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mena","family":"Milad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debolina","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Alpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon S.","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,20]]},"reference":[{"issue":"2","key":"50_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115(2):209\u2013218. doi: 10.1172\/JCI24282","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"50_CR2","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman SL (2003) Liver fibrosis\u2014from bench to bedside. J Hepatol 38(Suppl 1):S38\u2013S53","journal-title":"J Hepatol"},{"issue":"4","key":"50_CR3","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","volume":"275","author":"SL Friedman","year":"2000","unstructured":"Friedman SL (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275(4):2247\u20132250","journal-title":"J Biol Chem"},{"issue":"2","key":"50_CR4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bpg.2011.02.006","volume":"25","author":"SJ Forbes","year":"2011","unstructured":"Forbes SJ, Parola M (2011) Liver fibrogenic cells. Best Pract Res Clin Gastroenterol 25(2):207\u2013217. doi: 10.1016\/j.bpg.2011.02.006","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"50_CR5","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134(6):1655\u20131669. doi: 10.1053\/j.gastro.2008.03.003","journal-title":"Gastroenterology"},{"issue":"2","key":"50_CR6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","volume":"25","author":"UE Lee","year":"2011","unstructured":"Lee UE, Friedman SL (2011) Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 25(2):195\u2013206. doi: 10.1016\/j.bpg.2011.02.005","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"50_CR7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1872-034X.2011.00776.x","volume":"41","author":"N Kawada","year":"2011","unstructured":"Kawada N (2011) Evolution of hepatic fibrosis research. Hepatol Res 41(3):199\u2013208. doi: 10.1111\/j.1872-034X.2011.00776.x","journal-title":"Hepatol Res"},{"issue":"2","key":"50_CR8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bpg.2011.02.004","volume":"25","author":"P Starkel","year":"2011","unstructured":"Starkel P, Leclercq IA (2011) Animal models for the study of hepatic fibrosis. Best Pract Res Clin Gastroenterol 25(2):319\u2013333. doi: 10.1016\/j.bpg.2011.02.004","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"50_CR9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/1389200053586118","volume":"6","author":"D Farkas","year":"2005","unstructured":"Farkas D, Tannenbaum SR (2005) In vitro methods to study chemically-induced hepatotoxicity: a literature review. Curr Drug Metab 6(2):111\u2013125","journal-title":"Curr Drug Metab"},{"issue":"6","key":"50_CR10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-0773.1998.tb01475.x","volume":"83","author":"DE Johnston","year":"1998","unstructured":"Johnston DE, Kroening C (1998) Mechanism of early carbon tetrachloride toxicity in cultured rat hepatocytes. Pharmacol Toxicol 83(6):231\u2013239","journal-title":"Pharmacol Toxicol"},{"issue":"1","key":"50_CR11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-3565(25)32501-2","volume":"217","author":"R James","year":"1981","unstructured":"James R, Desmond P, Kupfer A, Schenker S, Branch RA (1981) The differential localization of various drug metabolizing systems within the rat liver lobule as determined by the hepatotoxins allyl alcohol, carbon tetrachloride and bromobenzene. J Pharmacol Exp Ther 217(1):127\u2013132","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"50_CR12","first-page":"83","volume":"35","author":"D Perrissoud","year":"1981","unstructured":"Perrissoud D, Auderset G, Reymond O, Maignan MF (1981) The effect of carbon tetrachloride on isolated rat hepatocytes. Virchows Arch B Cell Pathol Incl Mol Pathol 35(2):83\u201391","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"issue":"1","key":"50_CR13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0272-0590(86)90260-5","volume":"6","author":"JV Bruckner","year":"1986","unstructured":"Bruckner JV, MacKenzie WF, Muralidhara S, Luthra R, Kyle GM, Acosta D (1986) Oral toxicity of carbon tetrachloride: acute, subacute, and subchronic studies in rats. Fundam Appl Toxicol 6(1):16\u201334","journal-title":"Fundam Appl Toxicol"},{"key":"50_CR14","doi-asserted-by":"crossref","unstructured":"\u2022 Oumi N, Taniguchi KA, Kanai AM, Yasunaga M, Nakanishi T, Sato K (2012) A crucial role of bone morphogenetic protein signaling in the wound healing response in acute liver injury induced by carbon tetrachloride. Int J Hepatol 2012:476820. doi: 10.1155\/2012\/476820 . The results of this study show that in mice with a conditional knockout of Bmp1a, the wound-healing response triggered by CCl4-induced liver injury is retarded. Notably, aggravated histological features, reduced expression of albumin and Tdo2 gene expression, and decreased proliferation was observed; suggesting that BMP signaling plays a crucial role in ameliorating acute liver injury","DOI":"10.1155\/2012\/476820"},{"issue":"5 Pt 1","key":"50_CR15","first-page":"G1289","volume":"276","author":"GD LeSage","year":"1999","unstructured":"LeSage GD, Glaser SS, Marucci L, Benedetti A, Phinizy JL, Rodgers R et al (1999) Acute carbon tetrachloride feeding induces damage of large but not small cholangiocytes from BDL rat liver. Am J Physiol 276(5 Pt 1):G1289\u2013G1301","journal-title":"Am J Physiol"},{"issue":"2","key":"50_CR16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.510290242","volume":"29","author":"GD LeSage","year":"1999","unstructured":"LeSage GD, Benedetti A, Glaser S, Marucci L, Tretjak Z, Caligiuri A et al (1999) Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver. Hepatology 29(2):307\u2013319. doi: 10.1002\/hep.510290242","journal-title":"Hepatology"},{"issue":"1","key":"50_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/path.1711560106","volume":"156","author":"A Bosma","year":"1988","unstructured":"Bosma A, Brouwer A, Seifert WF, Knook DL (1988) Synergism between ethanol and carbon tetrachloride in the generation of liver fibrosis. J Pathol 156(1):15\u201321. doi: 10.1002\/path.1711560106","journal-title":"J Pathol"},{"key":"50_CR18","first-page":"237","volume":"117","author":"C Constandinou","year":"2005","unstructured":"Constandinou C, Henderson N, Iredale JP (2005) Modeling liver fibrosis in rodents. Methods Mol Med 117:237\u2013250. doi: 10.1385\/1-59259-940-0:237","journal-title":"Methods Mol Med"},{"issue":"6","key":"50_CR19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jhep.2009.09.008","volume":"51","author":"M Domenicali","year":"2009","unstructured":"Domenicali M, Caraceni P, Giannone F, Baldassarre M, Lucchetti G, Quarta C et al (2009) A novel model of CCl4-induced cirrhosis with ascites in the mouse. J Hepatol 51(6):991\u2013999. doi: 10.1016\/j.jhep.2009.09.008","journal-title":"J Hepatol"},{"issue":"4","key":"50_CR20","first-page":"367","volume":"41","author":"EE Frezza","year":"1994","unstructured":"Frezza EE, Gerunda GE, Farinati F, DeMaria N, Galligioni A, Plebani F et al (1994) CCL4-induced liver cirrhosis and hepatocellular carcinoma in rats: relationship to plasma zinc, copper and estradiol levels. Hepatogastroenterology 41(4):367\u2013369","journal-title":"Hepatogastroenterology"},{"issue":"5","key":"50_CR21","doi-asserted-by":"crossref","first-page":"G449","DOI":"10.1152\/ajpgi.00199.2012","volume":"304","author":"Y Liu","year":"2013","unstructured":"Liu Y, Meyer C, Xu C, Weng H, Hellerbrand C, ten Dijke P et al (2013) Animal models of chronic liver diseases. Am J Physiol Gastrointest Liver Physiol 304(5):G449\u2013G468. doi: 10.1152\/ajpgi.00199.2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"50_CR22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","volume":"102","author":"JP Iredale","year":"1998","unstructured":"Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S et al (1998) Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 102(3):538\u2013549. doi: 10.1172\/JCI1018","journal-title":"J Clin Invest"},{"key":"50_CR23","doi-asserted-by":"crossref","unstructured":"\u2022 Troeger JS, Mederacke I, Gwak GY, Dapito DH, Mu X, Hsu CC et al (2012) Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 143(4):1073\u20131083 e22. doi: 10.1053\/j.gastro.2012.06.036 . The results of this study show that deactivation of HSCs leads to the termination of fibrogenesis but these reverted HSCs are highly responsive to recurring fibrogenic stimulation","DOI":"10.1053\/j.gastro.2012.06.036"},{"issue":"3","key":"50_CR24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.taap.2007.11.010","volume":"228","author":"JS Kang","year":"2008","unstructured":"Kang JS, Wanibuchi H, Morimura K, Wongpoomchai R, Chusiri Y, Gonzalez FJ et al (2008) Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity. Toxicol Appl Pharmacol 228(3):295\u2013300. doi: 10.1016\/j.taap.2007.11.010","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"50_CR25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.taap.2006.11.036","volume":"219","author":"J Chilakapati","year":"2007","unstructured":"Chilakapati J, Korrapati MC, Shankar K, Hill RA, Warbritton A, Latendresse JR et al (2007) Role of CYP2E1 and saturation kinetics in the bioactivation of thioacetamide: effects of diet restriction and phenobarbital. Toxicol Appl Pharmacol 219(1):72\u201384. doi: 10.1016\/j.taap.2006.11.036","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"50_CR26","first-page":"386","volume":"208","author":"WR Porter","year":"1979","unstructured":"Porter WR, Gudzinowicz MJ, Neal RA (1979) Thioacetamide-induced hepatic necrosis. II. Pharmacokinetics of thioacetamide and thioacetamide-S-oxide in the rat. J Pharmacol Exp Ther 208(3):386\u2013391","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"50_CR27","first-page":"391","volume":"70","author":"R Bruck","year":"1997","unstructured":"Bruck R, Hershkoviz R, Lider O, Shirin H, Aeed H, Halpern Z (1997) The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injury. Yale J Biol Med 70(4):391\u2013402","journal-title":"Yale J Biol Med"},{"key":"50_CR28","doi-asserted-by":"crossref","unstructured":"\u2022 Ohyama T, Sato K, Kishimoto K, Yamazaki Y, Horiguchi N, Ichikawa T et al (2012) Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence. Br J Pharmacol 165(4b):1173\u20131187. doi: 10.1111\/j.1476-5381.2011.01599.x . This study explored the anti-fibrotic and antioxidative effect of azelnidipine, which is widely used in clinical practice as a calcium channel blocker. The results of the study showed that azelnidipine inhibited TGF-\u03b21- and AngII-induced HSC activation in vitro and attenuated CCl4- and TAA-induced liver fibrosis; suggesting that azelnidipine may be used as an anti-fibrotic therapeutic","DOI":"10.1111\/j.1476-5381.2011.01599.x"},{"issue":"5","key":"50_CR29","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jhep.2008.01.008","volume":"48","author":"P Newell","year":"2008","unstructured":"Newell P, Villanueva A, Friedman SL, Koike K, Llovet JM (2008) Experimental models of hepatocellular carcinoma. J Hepatol 48(5):858\u2013879. doi: 10.1016\/j.jhep.2008.01.008","journal-title":"J Hepatol"},{"key":"50_CR30","doi-asserted-by":"crossref","unstructured":"\u2022 Sakurai T, Kudo M, Umemura A, He G, Elsharkawy AM, Seki E et al (2013) p38alpha inhibits liver fibrogenesis and consequent hepatocarcinogenesis by curtailing accumulation of reactive oxygen species. Cancer Res 73(1):215\u2013224. doi: 10.1158\/0008-5472.CAN-12-1602 . In this study, the TAA mouse model was used to examine the role of the stress-activated protein kinase, p38\u03b1, in ROS metabolism, liver fibrogenesis, and hepatocarcinogenesis. The results of this study showed thatp38\u03b1 and its target HSP25\/HSP27 reduce ROS accumulation in liver parenchymal cells; suggesting a crucial role for these proteins in the protection against liver fibrosis and hepatocarcinoma","DOI":"10.1158\/0008-5472.CAN-12-1602"},{"issue":"10","key":"50_CR31","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1073\/pnas.78.10.6489","volume":"78","author":"MB Kroeger-Koepke","year":"1981","unstructured":"Kroeger-Koepke MB, Koepke SR, McClusky GA, Magee PN, Michejda CJ (1981) alpha-Hydroxylation pathway in the in vitro metabolism of carcinogenic nitrosamines: N-nitrosodimethylamine and N-nitroso-N-methylaniline. Proc Natl Acad Sci USA 78(10):6489\u20136493","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"50_CR32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jnci\/54.1.137","volume":"54","author":"LA Poirier","year":"1975","unstructured":"Poirier LA (1975) Hepatocarcinogenesis by diethylnitrosamine in rats fed high dietary levels of lipotropes. J Natl Cancer Inst 54(1):137\u2013140","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"50_CR33","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20031675","volume":"199","author":"T Yoshida","year":"2004","unstructured":"Yoshida T, Ogata H, Kamio M, Joo A, Shiraishi H, Tokunaga Y et al (2004) SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis. J Exp Med 199(12):1701\u20131707. doi: 10.1084\/jem.20031675","journal-title":"J Exp Med"},{"issue":"3","key":"50_CR34","first-page":"264","volume":"7","author":"JF Zheng","year":"2008","unstructured":"Zheng JF, Liang LJ (2008) Intra-portal transplantation of bone marrow stromal cells ameliorates liver fibrosis in mice. Hepatobiliary Pancreat Dis Int 7(3):264\u2013270","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"50_CR35","doi-asserted-by":"crossref","unstructured":"\u2022 Fuchs BC, Hoshida Y, Fujii T, Wei L, Yamada S, Lauwers GY et al (2014). Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology 59(4):1577\u20131590. doi: 10.1002\/hep.26898 . The results of this study showed that in the DEN rat model, CCl4 mouse model, and BDL rat model, the EGFR inhibitor, erlotinib, decreased liver injury, fibrosis, and hepatocyte proliferation. These results suggest that erlotinib, which is already FDA approved, may be a novel treatment option for high-risk cirrhosis patients for reducing fibrosis and preventing HCC","DOI":"10.1002\/hep.26898"},{"issue":"1","key":"50_CR36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/hep.510240129","volume":"24","author":"JP Iredale","year":"1996","unstructured":"Iredale JP, Benyon RC, Arthur MJ, Ferris WF, Alcolado R, Winwood PJ et al (1996) Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 24(1):176\u2013184. doi: 10.1002\/hep.510240129","journal-title":"Hepatology"},{"issue":"6","key":"50_CR37","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.2353\/ajpath.2009.090114","volume":"175","author":"P Fickert","year":"2009","unstructured":"Fickert P, Fuchsbichler A, Moustafa T, Wagner M, Zollner G, Halilbasic E et al (2009) Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts. Am J Pathol 175(6):2392\u20132405. doi: 10.2353\/ajpath.2009.090114","journal-title":"Am J Pathol"},{"key":"50_CR38","doi-asserted-by":"crossref","unstructured":"\u2022 Kim KH, Chen CC, Monzon RI, Lau LF (2013) Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts. Mol Cell Biol 33(10):2078\u20132090. doi: 10.1128\/MCB.00049-13 . The results of this study showed that CCN1, which is not required for normal liver development or regeneration, is upregulated in response to CCL4- or BDL-induced liver injury and functions to both prevent liver fibrosis and promote liver fibrosis regression. These findings identify the CCN1-signaling pathway as a possible target for the development of new therapeutic options for the treatment of liver fibrosis","DOI":"10.1128\/MCB.00049-13"},{"issue":"6","key":"50_CR39","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/gast.2001.23984","volume":"120","author":"E Jacquemin","year":"2001","unstructured":"Jacquemin E, De Vree JM, Cresteil D, Sokal EM, Sturm E, Dumont M et al (2001) The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 120(6):1448\u20131458","journal-title":"Gastroenterology"},{"issue":"7","key":"50_CR40","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0092-8674(94)90446-4","volume":"77","author":"S Ruetz","year":"1994","unstructured":"Ruetz S, Gros P (1994) Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 77(7):1071\u20131081. doi: 10.1016\/0092-8674(94)90446-4","journal-title":"Cell"},{"issue":"3","key":"50_CR41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","volume":"75","author":"JJ Smit","year":"1993","unstructured":"Smit JJ, Schinkel AH, Oude Elferink RP, Groen AK, Wagenaar E, van Deemter L et al (1993) Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75(3):451\u2013462","journal-title":"Cell"},{"issue":"3","key":"50_CR42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(00)81370-7","volume":"87","author":"A Helvoort van","year":"1996","unstructured":"van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P et al (1996) MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87(3):507\u2013517. doi: 10.1016\/S0092-8674(00)81370-7","journal-title":"Cell"},{"issue":"5","key":"50_CR43","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00424-006-0062-9","volume":"453","author":"Oude Elferink RP","year":"2007","unstructured":"Oude Elferink RP (2007) Paulusma CC. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Pflugers Arch 453(5):601\u2013610. doi: 10.1007\/s00424-006-0062-9","journal-title":"Pflugers Arch"},{"issue":"1","key":"50_CR44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2006-960172","volume":"27","author":"M Trauner","year":"2007","unstructured":"Trauner M, Fickert P, Wagner M (2007) MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. Semin Liver Dis 27(1):77\u201398. doi: 10.1055\/s-2006-960172","journal-title":"Semin Liver Dis"},{"key":"50_CR45","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Cai SY, Mennone A, Soroka CJ, Boyer JL (2014) Altered expression and function of canalicular transporters during early development of cholestatic liver injury in Abcb4-deficient mice. Am J Physiol Gastrointest Liver Physiol 306(8):G670\u2013G676. doi: 10.1152\/ajpgi.00334.2013 . The results of this study showed that the canalicular transporters that determine the formation of bile, including: Bsep, Mrp2, ABCg5, Ost-\u03b1, and Ntcp, are altered early in the development of cholestasis in Abcd4 \u2212\/\u2212 mice, suggesting that the disregulation of these transporters may play a role in the pathogenesis of cholestasis","DOI":"10.1152\/ajpgi.00334.2013"},{"issue":"1","key":"50_CR46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.gastro.2011.09.051","volume":"142","author":"P Fickert","year":"2012","unstructured":"Fickert P, Magnes C, Guelly C, Thueringer A, Frank S et al (2012) Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury. Gastroenterology 142(1):140\u2013151. doi: 10.1053\/j.gastro.2011.09.051","journal-title":"Gastroenterology"},{"key":"50_CR47","doi-asserted-by":"crossref","unstructured":"\u2022 Fickert P, Pollheimer MJ, Silbert D, Moustafa T, Halilbasic E, Krones E et al (2013) Differential effects of norUDCA and UDCA in obstructive cholestasis in mice. J Hepatol 58(6):1201\u20131208. doi: 10.1016\/j.jhep.2013.01.026 . The results of this study showed that the UDCA derivative, norUDCA, which is significantly less toxic than UDCA, ameliorated liver injury in Abcb4 \u2212\/\u2212 BDL mice; suggesting that there are important differences in the metabolism and therapeutic implications of UDCA and norUDCA","DOI":"10.1016\/j.jhep.2013.01.026"},{"issue":"4","key":"50_CR48","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0014-5793(69)80255-3","volume":"4","author":"D Keppler","year":"1969","unstructured":"Keppler D, Frohlich J, Reutter W, Wieland O, Decker K (1969) Changes in uridine nucleotides during liver perfusion with D-galactosamine. FEBS Lett 4(4):278\u2013280","journal-title":"FEBS Lett"},{"issue":"2","key":"50_CR49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-5793(82)80180-4","volume":"145","author":"M Mangeney-Andreani","year":"1982","unstructured":"Mangeney-Andreani M, Sire O, Montagne-Clavel J, Nordmann R, Nordmann J (1982) Inhibitory effect of d-galactosamine administration on fatty acid oxidation in rat hepatocytes. FEBS Lett 145(2):267\u2013270","journal-title":"FEBS Lett"},{"issue":"2","key":"50_CR50","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1432-1033.1983.tb07751.x","volume":"136","author":"O Sire","year":"1983","unstructured":"Sire O, Mangeney M, Montagne J, Nordmann R, Nordmann J (1983) Carnitine palmitoyltransferase I. Inhibition by d-galactosamine and role of phospholipids. Eur J Biochem 136(2):371\u2013375","journal-title":"Eur J Biochem"},{"issue":"10","key":"50_CR51","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/0006-2952(78)90097-7","volume":"27","author":"G Stramentinoli","year":"1978","unstructured":"Stramentinoli G, Gualano M, Ideo G (1978) Protective role of S-adenosyl-l-methionine on liver injury induced by d-galactosamine in rats. Biochem Pharmacol 27(10):1431\u20131433","journal-title":"Biochem Pharmacol"},{"issue":"Suppl 3","key":"50_CR52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003495-199000403-00011","volume":"40","author":"P Almasio","year":"1990","unstructured":"Almasio P, Bortolini M, Pagliaro L, Coltorti M (1990) Role of S-adenosyl-l-methionine in the treatment of intrahepatic cholestasis. Drugs 40(Suppl 3):111\u2013123","journal-title":"Drugs"},{"issue":"1","key":"50_CR53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2036.1993.tb00065.x","volume":"7","author":"E Osman","year":"1993","unstructured":"Osman E, Owen JS, Burroughs AK (1993) Review article: S-Adenosyl-l-Methionine\u2014a new therapeutic agent in liver disease? Aliment Pharmacol Ther 7(1):21\u201328. doi: 10.1111\/j.1365-2036.1993.tb00065.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"50_CR54","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1124\/dmd.106.009308","volume":"34","author":"FA Crocenzi","year":"2006","unstructured":"Crocenzi FA, Pellegrino JM, Catania VA, Luquita MG, Roma MG, Mottino AD et al (2006) Galactosamine prevents ethinylestradiol-induced cholestasis. Drug Metab Dispos 34(6):993\u2013997. doi: 10.1124\/dmd.106.009308","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"50_CR55","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0925-4773(02)00338-6","volume":"120","author":"N Fausto","year":"2003","unstructured":"Fausto N, Campbell JS (2003) The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 120(1):117\u2013130","journal-title":"Mech Dev"},{"issue":"4","key":"50_CR56","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/path.1163","volume":"197","author":"S Forbes","year":"2002","unstructured":"Forbes S, Vig P, Poulsom R, Thomas H, Alison M (2002) Hepatic stem cells. J Pathol 197(4):510\u2013518. doi: 10.1002\/path.1163","journal-title":"J Pathol"},{"issue":"11","key":"50_CR57","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/bies.20311","volume":"27","author":"B Knight","year":"2005","unstructured":"Knight B, Matthews VB, Olynyk JK, Yeoh GC (2005) Jekyll and Hyde: evolving perspectives on the function and potential of the adult liver progenitor (oval) cell. BioEssays 27(11):1192\u20131202. doi: 10.1002\/bies.20311","journal-title":"BioEssays"},{"issue":"4","key":"50_CR58","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1055\/s-2004-815564","volume":"23","author":"TA Roskams","year":"2003","unstructured":"Roskams TA, Libbrecht L, Desmet VJ (2003) Progenitor cells in diseased human liver. Semin Liver Dis 23(4):385\u2013396. doi: 10.1055\/s-2004-815564","journal-title":"Semin Liver Dis"},{"issue":"6","key":"50_CR59","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1524-475x.2001.00467.x","volume":"9","author":"S Sell","year":"2001","unstructured":"Sell S (2001) The role of progenitor cells in repair of liver injury and in liver transplantation. Wound Repair Regen 9(6):467\u2013482","journal-title":"Wound Repair Regen"},{"issue":"8","key":"50_CR60","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1634\/stemcells.2006-0063","volume":"24","author":"MH Walkup","year":"2006","unstructured":"Walkup MH, Gerber DA (2006) Hepatic stem cells: in search of. Stem Cells 24(8):1833\u20131840. doi: 10.1634\/stemcells.2006-0063","journal-title":"Stem Cells"},{"issue":"6","key":"50_CR61","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.2353\/ajpath.2009.080338","volume":"175","author":"J Kon","year":"2009","unstructured":"Kon J, Ichinohe N, Ooe H, Chen Q, Sasaki K, Mitaka T (2009) Thy1-positive cells have bipotential ability to differentiate into hepatocytes and biliary epithelial cells in galactosamine-induced rat liver regeneration. Am J Pathol 175(6):2362\u20132371","journal-title":"Am J Pathol"},{"issue":"1","key":"50_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0959-9673.2006.00465.x","volume":"87","author":"QM Anstee","year":"2006","unstructured":"Anstee QM, Goldin RD (2006) Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 87(1):1\u201316. doi: 10.1111\/j.0959-9673.2006.00465.x","journal-title":"Int J Exp Pathol"},{"issue":"5","key":"50_CR63","doi-asserted-by":"crossref","first-page":"G1070","DOI":"10.1152\/ajpgi.00228.2004","volume":"287","author":"D Gao","year":"2004","unstructured":"Gao D, Wei C, Chen L, Huang J, Yang S, Diehl AM (2004) Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease. Am J Physiol Gastrointest Liver Physiol 287(5):G1070\u2013G1077. doi: 10.1152\/ajpgi.00228.2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"11","key":"50_CR64","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1046\/j.1440-1746.2003.03198.x","volume":"18","author":"R Kirsch","year":"2003","unstructured":"Kirsch R, Clarkson V, Shephard EG, Marais DA, Jaffer MA, Woodburne VE et al (2003) Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J Gastroenterol Hepatol 18(11):1272\u20131282","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"50_CR65","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jhep.2008.03.026","volume":"49","author":"CZ Larter","year":"2008","unstructured":"Larter CZ, Yeh MM, Williams J, Bell-Anderson KS, Farrell GC (2008) MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes. J Hepatol 49(3):407\u2013416. doi: 10.1016\/j.jhep.2008.03.026","journal-title":"J Hepatol"},{"issue":"1","key":"50_CR66","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/labinvest.3700489","volume":"87","author":"IA Leclercq","year":"2007","unstructured":"Leclercq IA, Lebrun VA, Starkel P, Horsmans YJ (2007) Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARgamma agonist pioglitazone. Lab Invest 87(1):56\u201365. doi: 10.1038\/labinvest.3700489","journal-title":"Lab Invest"},{"issue":"1","key":"50_CR67","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2003.09.020","volume":"40","author":"ME Rinella","year":"2004","unstructured":"Rinella ME, Green RM (2004) The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J Hepatol 40(1):47\u201351","journal-title":"J Hepatol"},{"key":"50_CR68","doi-asserted-by":"crossref","unstructured":"\u2022 Jung YA, Choi YK, Jung GS, Seo HY, Kim HS, Jang BK et al (2014) Sitagliptin attenuates methionine\/choline-deficient diet-induced steatohepatitis. Diabetes Res Clin Pract 105(1):47\u201357. doi: 10.1016\/j.diabres.2014.04.028 . The results of this study show that sitagliptin, a drug commonly prescribed to type II diabetes patients to lower blood sugar, attenuates hepatic steatosis, inflammation, and fibrosis, suggesting that sitagliptin may be a promising option for the treatment of liver fibrosis","DOI":"10.1016\/j.diabres.2014.04.028"},{"issue":"2","key":"50_CR69","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/carcin\/16.2.327","volume":"16","author":"KA Costa da","year":"1995","unstructured":"da Costa KA, Garner SC, Chang J, Zeisel SH (1995) Effects of prolonged (1\u00a0year) choline deficiency and subsequent re-feeding of choline on 1,2-sn-diradylglycerol, fatty acids and protein kinase C in rat liver. Carcinogenesis 16(2):327\u2013334","journal-title":"Carcinogenesis"},{"issue":"3","key":"50_CR70","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0304-3835(87)90022-X","volume":"36","author":"AK Ghoshal","year":"1987","unstructured":"Ghoshal AK, Rushmore TH, Farber E (1987) Initiation of carcinogenesis by a dietary deficiency of choline in the absence of added carcinogens. Cancer Lett 36(3):289\u2013296","journal-title":"Cancer Lett"},{"issue":"2","key":"50_CR71","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MOG.0b013e32834e7b4b","volume":"28","author":"KD Corbin","year":"2012","unstructured":"Corbin KD, Zeisel SH (2012) Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr Opin Gastroenterol 28(2):159\u2013165. doi: 10.1097\/MOG.0b013e32834e7b4b","journal-title":"Curr Opin Gastroenterol"},{"issue":"6","key":"50_CR72","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jhep.2012.07.003","volume":"57","author":"NJW Wit de","year":"2012","unstructured":"de Wit NJW, Afman LA, Mensink M, M\u00fcller M (2012) Phenotyping the effect of diet on non-alcoholic fatty liver disease. J Hepatol 57(6):1370\u20131373. doi: 10.1016\/j.jhep.2012.07.003","journal-title":"J Hepatol"},{"issue":"42","key":"50_CR73","doi-asserted-by":"crossref","first-page":"27043","DOI":"10.1074\/jbc.273.42.27043","volume":"273","author":"CJ Walkey","year":"1998","unstructured":"Walkey CJ, Yu L, Agellon LB, Vance DE (1998) Biochemical and evolutionary significance of phospholipid methylation. J Biol Chem 273(42):27043\u201327046","journal-title":"J Biol Chem"},{"issue":"1","key":"50_CR74","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jss.2007.12.784","volume":"152","author":"F Berthiaume","year":"2009","unstructured":"Berthiaume F, Barbe L, Mokuno Y, MacDonald AD, Jindal R, Yarmush ML (2009) Steatosis reversibly increases hepatocyte sensitivity to hypoxia-reoxygenation injury. J Surg Res 152(1):54\u201360. doi: 10.1016\/j.jss.2007.12.784","journal-title":"J Surg Res"},{"issue":"5","key":"50_CR75","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/carcin\/21.5.983","volume":"21","author":"K Hensley","year":"2000","unstructured":"Hensley K, Kotake Y, Sang H, Pye QN, Wallis GL, Kolker LM et al (2000) Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. Carcinogenesis 21(5):983\u2013989","journal-title":"Carcinogenesis"},{"issue":"2","key":"50_CR76","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10753-007-9053-z","volume":"31","author":"SS Koca","year":"2008","unstructured":"Koca SS, Bahcecioglu IH, Poyrazoglu OK, Ozercan IH, Sahin K, Ustundag B (2008) The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. Inflammation 31(2):91\u201398. doi: 10.1007\/s10753-007-9053-z","journal-title":"Inflammation"},{"issue":"3","key":"50_CR77","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gut.2005.071118","volume":"55","author":"K Tomita","year":"2006","unstructured":"Tomita K, Tamiya G, Ando S, Ohsumi K, Chiyo T, Mizutani A et al (2006) Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 55(3):415\u2013424. doi: 10.1136\/gut.2005.071118","journal-title":"Gut"},{"issue":"12","key":"50_CR78","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353(12):1261\u20131273. doi: 10.1056\/NEJMra043898","journal-title":"N Engl J Med"},{"issue":"2","key":"50_CR79","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.22042","volume":"47","author":"ME Gershwin","year":"2008","unstructured":"Gershwin ME, Mackay IR (2008) The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 47(2):737\u2013745. doi: 10.1002\/hep.22042","journal-title":"Hepatology"},{"key":"50_CR80","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pathol-020712-164014","volume":"8","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield GM, Gershwin ME (2013) The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol 8:303\u2013330. doi: 10.1146\/annurev-pathol-020712-164014","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"50_CR81","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.4049\/jimmunol.173.4.2315","volume":"173","author":"S Koarada","year":"2004","unstructured":"Koarada S, Wu Y, Fertig N, Sass DA, Nalesnik M, Todd JA et al (2004) Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain. J Immunol 173(4):2315\u20132323","journal-title":"J Immunol"},{"issue":"4","key":"50_CR82","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/hep.21390","volume":"44","author":"AL Mason","year":"2006","unstructured":"Mason AL (2006) An autoimmune biliary disease mouse model for primary biliary cirrhosis: something for everyone. Hepatology 44(4):1047\u20131050. doi: 10.1002\/hep.21390","journal-title":"Hepatology"},{"issue":"5","key":"50_CR83","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.20051911","volume":"203","author":"J Irie","year":"2006","unstructured":"Irie J, Wu Y, Wicker LS, Rainbow D, Nalesnik MA, Hirsch R et al (2006) NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med 203(5):1209\u20131219. doi: 10.1084\/jem.20051911","journal-title":"J Exp Med"},{"issue":"1","key":"50_CR84","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cellimm.2011.01.005","volume":"268","author":"Y Moritoki","year":"2011","unstructured":"Moritoki Y, Tsuda M, Tsuneyama K, Zhang W, Yoshida K, Lian ZX et al (2011) B cells promote hepatic inflammation, biliary cyst formation, and salivary gland inflammation in the NOD.c3c4 model of autoimmune cholangitis. Cell Immunol 268(1):16\u201323. doi: 10.1016\/j.cellimm.2011.01.005","journal-title":"Cell Immunol"},{"issue":"3","key":"50_CR85","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.4049\/jimmunol.177.3.1655","volume":"177","author":"S Oertelt","year":"2006","unstructured":"Oertelt S, Lian ZX, Cheng CM, Chuang YH, Padgett KA, He XS et al (2006) Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol 177(3):1655\u20131660","journal-title":"J Immunol"},{"issue":"2","key":"50_CR86","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1074-7613(00)80170-3","volume":"12","author":"L Gorelik","year":"2000","unstructured":"Gorelik L, Flavell RA (2000) Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12(2):171\u2013181","journal-title":"Immunity"},{"issue":"3","key":"50_CR87","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MOG.0b013e32833755aa","volume":"26","author":"Y Ueno","year":"2010","unstructured":"Ueno Y, Ambrosini YM, Moritoki Y, Ridgway WM, Gershwin ME (2010) Murine models of autoimmune cholangitis. Curr Opin Gastroenterol 26(3):274\u2013279. doi: 10.1097\/MOG.0b013e32833755aa","journal-title":"Curr Opin Gastroenterol"},{"issue":"6","key":"50_CR88","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/hep.22226","volume":"47","author":"GX Yang","year":"2008","unstructured":"Yang GX, Lian ZX, Chuang YH, Moritoki Y, Lan RY, Wakabayashi K et al (2008) Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology 47(6):1974\u20131982. doi: 10.1002\/hep.22226","journal-title":"Hepatology"},{"issue":"5","key":"50_CR89","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/hep.21385","volume":"44","author":"K Wakabayashi","year":"2006","unstructured":"Wakabayashi K, Lian ZX, Moritoki Y, Lan RY, Tsuneyama K, Chuang YH et al (2006) IL-2 receptor alpha(\u2212\/\u2212) mice and the development of primary biliary cirrhosis. Hepatology 44(5):1240\u20131249. doi: 10.1002\/hep.21385","journal-title":"Hepatology"},{"issue":"4","key":"50_CR90","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/1074-7613(95)90180-9","volume":"3","author":"DM Willerford","year":"1995","unstructured":"Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW (1995) Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3(4):521\u2013530","journal-title":"Immunity"},{"issue":"1","key":"50_CR91","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.22591","volume":"49","author":"W Hsu","year":"2009","unstructured":"Hsu W, Zhang W, Tsuneyama K, Moritoki Y, Ridgway WM, Ansari AA et al (2009) Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(\u2212\/\u2212) mice. Hepatology 49(1):133\u2013140. doi: 10.1002\/hep.22591","journal-title":"Hepatology"},{"issue":"5","key":"50_CR92","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/j.gastro.2008.02.020","volume":"134","author":"JT Salas","year":"2008","unstructured":"Salas JT, Banales JM, Sarvide S, Recalde S, Ferrer A, Uriarte I et al (2008) Ae2a, b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology 134(5):1482\u20131493. doi: 10.1053\/j.gastro.2008.02.020","journal-title":"Gastroenterology"},{"issue":"5","key":"50_CR93","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00424-003-1180-2","volume":"447","author":"MF Romero","year":"2004","unstructured":"Romero MF, Fulton CM, Boron WF (2004) The SLC4 family of HCO 3\u2014transporters. Pflugers Arch 447(5):495\u2013509. doi: 10.1007\/s00424-003-1180-2","journal-title":"Pflugers Arch"},{"issue":"6","key":"50_CR94","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/hep.1840190613","volume":"19","author":"E Martinez-Anso","year":"1994","unstructured":"Martinez-Anso E, Castillo JE, Diez J, Medina JF, Prieto J (1994) Immunohistochemical detection of chloride\/bicarbonate anion exchangers in human liver. Hepatology 19(6):1400\u20131406","journal-title":"Hepatology"},{"issue":"3","key":"50_CR95","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jhep.2008.12.006","volume":"50","author":"P Fickert","year":"2009","unstructured":"Fickert P, Trauner M (2009) When lightning strikes twice: the plot thickens for a dual role of the anion exchanger 2 (AE2\/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosis. J Hepatol 50(3):633\u2013635. doi: 10.1016\/j.jhep.2008.12.006","journal-title":"J Hepatol"},{"issue":"4","key":"50_CR96","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.21123","volume":"43","author":"RY Lan","year":"2006","unstructured":"Lan RY, Cheng C, Lian ZX, Tsuneyama K, Yang GX, Moritoki Y et al (2006) Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 43(4):729\u2013737. doi: 10.1002\/hep.21123","journal-title":"Hepatology"},{"issue":"5","key":"50_CR97","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1034\/j.1600-0676.2000.020005351.x","volume":"20","author":"DE Jones","year":"2000","unstructured":"Jones DE, Palmer JM, Kirby JA, De Cruz DJ, McCaughan GW, Sedgwick JD et al (2000) Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy. Liver 20(5):351\u2013356","journal-title":"Liver"},{"issue":"1","key":"50_CR98","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/hep.510300123","volume":"30","author":"DE Jones","year":"1999","unstructured":"Jones DE, Palmer JM, Yeaman SJ, Kirby JA, Bassendine MF (1999) Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: a mouse model of primary biliary cirrhosis. Hepatology 30(1):65\u201370. doi: 10.1002\/hep.510300123","journal-title":"Hepatology"},{"issue":"5","key":"50_CR99","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1053\/jhep.2002.32540","volume":"35","author":"M Sasaki","year":"2002","unstructured":"Sasaki M, Long SA, Van De Water J, He XS, Shultz L, Coppel RL (2002) The SJL\/J mouse is not a model for PBC. Hepatology 35(5):1284\u20131286. doi: 10.1053\/jhep.2002.32540","journal-title":"Hepatology"},{"key":"50_CR100","doi-asserted-by":"crossref","unstructured":"Jones DE, Palmer JM, Burt AD, Kirby JA (2008) The specificity of liver inflammation in mouse models of primary biliary cirrhosis. Hepatology 48(4):1353\u20131354; author reply 4\u20135. doi: 10.1002\/hep.22522","DOI":"10.1002\/hep.22522"},{"issue":"2","key":"50_CR101","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.22390","volume":"48","author":"K Wakabayashi","year":"2008","unstructured":"Wakabayashi K, Lian ZX, Leung PS, Moritoki Y, Tsuneyama K, Kurth MJ et al (2008) Loss of tolerance in C57BL\/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 48(2):531\u2013540. doi: 10.1002\/hep.22390","journal-title":"Hepatology"},{"issue":"9","key":"50_CR102","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.4049\/jimmunol.174.9.5874","volume":"174","author":"K Amano","year":"2005","unstructured":"Amano K, Leung PS, Rieger R, Quan C, Wang X, Marik J et al (2005) Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 174(9):5874\u20135883","journal-title":"J Immunol"},{"issue":"1","key":"50_CR103","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clinre.2011.07.007","volume":"36","author":"AR Concepcion","year":"2012","unstructured":"Concepcion AR, Medina JF (2012) Approaches to the pathogenesis of primary biliary cirrhosis through animal models. Clin Res Hepatol Gastroenterol 36(1):21\u201328. doi: 10.1016\/j.clinre.2011.07.007","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"50_CR104","doi-asserted-by":"crossref","unstructured":"\u2022 Dhirapong A, Yang GX, Nadler S, Zhang W, Tsuneyama K, Leung P et al (2013) Therapeutic effect of cytotoxic T lymphocyte antigen 4\/immunoglobulin on a murine model of primary biliary cirrhosis. Hepatology 57(2):708\u2013715. doi: 10.1002\/hep.26067 . The results of this study showed that CTLA-4-Ig treatment completely inhibits the development of cholangitis in a mouse model of PBC (2OA-BSA). Additionally, treatment with CTLA-4-Ig after the development of cholangitis reduced T-cell infiltrates and cholangiocyte damage; therefore, CTLA-4-Ig may prove to be a new treatment option for PBC patients","DOI":"10.1002\/hep.26067"},{"issue":"6","key":"50_CR105","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.23238","volume":"50","author":"Y Moritoki","year":"2009","unstructured":"Moritoki Y, Lian ZX, Lindor K, Tuscano J, Tsuneyama K, Zhang W et al (2009) B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice. Hepatology 50(6):1893\u20131903. doi: 10.1002\/hep.23238","journal-title":"Hepatology"},{"issue":"6","key":"50_CR106","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/0016-5085(90)91096-O","volume":"98","author":"MK Porayko","year":"1990","unstructured":"Porayko MK, Wiesner RH, LaRusso NF, Ludwig J, MacCarty RL, Steiner BL et al (1990) Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology 98(6):1594\u20131602","journal-title":"Gastroenterology"},{"issue":"2","key":"50_CR107","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","volume":"51","author":"R Chapman","year":"2010","unstructured":"Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B et al (2010) Diagnosis and management of primary sclerosing cholangitis. Hepatology 51(2):660\u2013678. doi: 10.1002\/hep.23294","journal-title":"Hepatology"},{"issue":"5 Pt 1","key":"50_CR108","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(91)70019-T","volume":"100","author":"R Olsson","year":"1991","unstructured":"Olsson R, Danielsson A, Jarnerot G, Lindstrom E, Loof L, Rolny P et al (1991) Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 100(5 Pt 1):1319\u20131323","journal-title":"Gastroenterology"},{"issue":"6","key":"50_CR109","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","volume":"43","author":"Y Popov","year":"2005","unstructured":"Popov Y, Patsenker E, Fickert P, Trauner M, Schuppan D (2005) Mdr2 (Abcb4)\u2212\/\u2212 mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J Hepatol 43(6):1045\u20131054. doi: 10.1016\/j.jhep.2005.06.025","journal-title":"J Hepatol"},{"issue":"1","key":"50_CR110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","volume":"127","author":"P Fickert","year":"2004","unstructured":"Fickert P, Fuchsbichler A, Wagner M, Zollner G, Kaser A, Tilg H et al (2004) Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 127(1):261\u2013274","journal-title":"Gastroenterology"},{"issue":"2","key":"50_CR111","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.gastro.2005.10.018","volume":"130","author":"P Fickert","year":"2006","unstructured":"Fickert P, Wagner M, Marschall HU, Fuchsbichler A, Zollner G, Tsybrovskyy O et al (2006) 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 130(2):465\u2013481. doi: 10.1053\/j.gastro.2005.10.018","journal-title":"Gastroenterology"},{"issue":"6","key":"50_CR112","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bpg.2011.10.009","volume":"25","author":"MJ Pollheimer","year":"2011","unstructured":"Pollheimer MJ, Halilbasic E, Fickert P, Trauner M (2011) Pathogenesis of primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 25(6):727\u2013739. doi: 10.1016\/j.bpg.2011.10.009","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"4","key":"50_CR113","doi-asserted-by":"crossref","first-page":"1498\u2013508, 508 e","DOI":"10.1053\/j.gastro.2011.06.052","volume":"141","author":"R Fiorotto","year":"2011","unstructured":"Fiorotto R, Scirpo R, Trauner M, Fabris L, Hoque R, Spirli C et al (2011) Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-kappaB-mediated inflammatory response in mice. Gastroenterology 141(4):1498\u2013508, 508 e1\u20135. doi: 10.1053\/j.gastro.2011.06.052","journal-title":"Gastroenterology"},{"issue":"2","key":"50_CR114","doi-asserted-by":"crossref","first-page":"G491","DOI":"10.1152\/ajpgi.00452.2003","volume":"287","author":"PG Blanco","year":"2004","unstructured":"Blanco PG, Zaman MM, Junaidi O, Sheth S, Yantiss RK, Nasser IA et al (2004) Induction of colitis in cftr\u2212\/\u2212 mice results in bile duct injury. Am J Physiol Gastrointest Liver Physiol 287(2):G491\u2013G496. doi: 10.1152\/ajpgi.00452.2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"11","key":"50_CR115","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/bjs.1800821110","volume":"82","author":"PJ Neilly","year":"1995","unstructured":"Neilly PJ, Gardiner KR, Kirk SJ, Jennings G, Anderson NH, Elia M et al (1995) Endotoxaemia and cytokine production in experimental colitis. Br J Surg 82(11):1479\u20131482","journal-title":"Br J Surg"},{"issue":"4","key":"50_CR116","doi-asserted-by":"crossref","first-page":"G474","DOI":"10.1152\/ajpgi.00055.2012","volume":"303","author":"CR Martin","year":"2012","unstructured":"Martin CR, Zaman MM, Ketwaroo GA, Bhutta AQ, Coronel E, Popov Y et al (2012) CFTR dysfunction predisposes to fibrotic liver disease in a murine model. Am J Physiol Gastrointest Liver Physiol 303(4):G474\u2013G481. doi: 10.1152\/ajpgi.00055.2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"50_CR117","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2353\/ajpath.2007.061133","volume":"171","author":"P Fickert","year":"2007","unstructured":"Fickert P, Stoger U, Fuchsbichler A, Moustafa T, Marschall HU, Weiglein AH et al (2007) A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol 171(2):525\u2013536. doi: 10.1152\/ajpgi.00055.2012","journal-title":"Am J Pathol"},{"key":"50_CR118","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Miyao M, Ozeki M, Abiru H, Manabe S, Kotani H, Tsuruyama T et al (2013) Bile canalicular abnormalities in the early phase of a mouse model of sclerosing cholangitis. Dig Liver Dis 45(3):216\u2013225. 10.1016\/j.dld.2012.09.007 . The results of this study validate DDC, the mouse model that is used for the early phases of PSC, by showing that bile canalicular abnormalities occur during the early phase of sclerosis","DOI":"10.1016\/j.dld.2012.09.007"},{"issue":"6","key":"50_CR119","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","volume":"51","author":"MP Manns","year":"2010","unstructured":"Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D et al (2010) Diagnosis and management of autoimmune hepatitis. Hepatology 51(6):2193\u20132213. doi: 10.1002\/hep.23584","journal-title":"Hepatology"},{"issue":"1","key":"50_CR120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004836-200207000-00016","volume":"35","author":"J Kogan","year":"2002","unstructured":"Kogan J, Safadi R, Ashur Y, Shouval D, Ilan Y (2002) Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients. J Clin Gastroenterol 35(1):75\u201381","journal-title":"J Clin Gastroenterol"},{"key":"50_CR121","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1542-3565(04)00246-0","volume":"2","author":"W Kessler","year":"2004","unstructured":"Kessler W, Cummings O, Eckert G, Chalasani N, Lumeng L, Kwo P (2004) Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2:625\u2013631","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"50_CR122","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1089-3261(02)00018-1","volume":"6","author":"D Vergani","year":"2002","unstructured":"Vergani D, Choudhuri K, Bogdanos DP, Mieli-Vergani G (2002) Pathogenesis of autoimmune hepatitis. Clin Liver Dis 6(3):727\u2013737","journal-title":"Clin Liver Dis"},{"issue":"1","key":"50_CR123","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","volume":"354","author":"EL Krawitt","year":"2006","unstructured":"Krawitt EL (2006) Autoimmune hepatitis. N Engl J Med 354(1):54\u201366. doi: 10.1056\/NEJMra050408","journal-title":"N Engl J Med"},{"issue":"5","key":"50_CR124","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nm1749","volume":"14","author":"S Perruche","year":"2008","unstructured":"Perruche S, Zhang P, Liu Y, Saas P, Bluestone JA, Chen W (2008) CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells. Nat Med 14(5):528\u2013535. doi: 10.1038\/nm1749","journal-title":"Nat Med"},{"issue":"3","key":"50_CR125","doi-asserted-by":"crossref","first-page":"G525","DOI":"10.1152\/ajpgi.00286.2002","volume":"284","author":"C Schramm","year":"2003","unstructured":"Schramm C, Protschka M, Kohler HH, Podlech J, Reddehase MJ, Schirmacher P et al (2003) Impairment of TGF-beta signaling in T cells increases susceptibility to experimental autoimmune hepatitis in mice. Am J Physiol Gastrointest Liver Physiol 284(3):G525\u2013G535. doi: 10.1152\/ajpgi.00286.2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"50_CR126","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.4049\/jimmunol.166.10.6413","volume":"166","author":"JD Gorham","year":"2001","unstructured":"Gorham JD, Lin JT, Sung JL, Rudner LA, French MA (2001) Genetic regulation of autoimmune disease: BALB\/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis. J Immunol 166(10):6413\u20136422","journal-title":"J Immunol"},{"issue":"4","key":"50_CR127","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1586\/egh.10.42","volume":"4","author":"AJ Czaja","year":"2010","unstructured":"Czaja AJ (2010) Animal models of autoimmune hepatitis. Expert Rev Gastroenterol Hepatol 4(4):429\u2013443. doi: 10.1586\/egh.10.42","journal-title":"Expert Rev Gastroenterol Hepatol"}],"container-title":["Current Pathobiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40139-014-0050-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40139-014-0050-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40139-014-0050-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T18:33:21Z","timestamp":1746383601000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40139-014-0050-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,20]]},"references-count":127,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["50"],"URL":"https:\/\/doi.org\/10.1007\/s40139-014-0050-2","relation":{},"ISSN":["2167-485X"],"issn-type":[{"value":"2167-485X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,20]]}}}